Expert Opinion on Therapeutic Patents,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 13, 2025
Introduction
Metabotropic
glutamate
receptor
4
(mGluR4)
regulates
disease
by
modulating
neurotransmitter
release
and
synaptic
plasticity
has
been
implicated
in
various
diseases,
including
neurodegenerative
disorders
psychiatric
conditions,
where
its
dysregulation
can
impact
function
neuronal
signaling.
Nature Medicine,
Journal Year:
2023,
Volume and Issue:
29(3), P. 679 - 688
Published: March 1, 2023
Abstract
The
genetic
etiologies
of
more
than
half
rare
diseases
remain
unknown.
Standardized
genome
sequencing
and
phenotyping
large
patient
cohorts
provide
an
opportunity
for
discovering
the
unknown
etiologies,
but
this
depends
on
efficient
powerful
analytical
methods.
We
built
a
compact
database,
‘Rareservoir’,
containing
variant
genotypes
phenotypes
77,539
participants
sequenced
by
100,000
Genomes
Project.
then
used
Bayesian
association
method
BeviMed
to
infer
associations
between
genes
each
269
disease
classes
assigned
clinicians
participants.
identified
241
known
19
previously
unidentified
associations.
validated
with
ERG
,
PMEPA1
GPR156
searching
pedigrees
in
other
using
bioinformatic
experimental
approaches.
evidence
that
(1)
loss-of-function
variants
Erythroblast
Transformation
Specific
(ETS)-family
transcription
factor
encoding
gene
lead
primary
lymphoedema,
(2)
truncating
last
exon
transforming
growth
factor-β
regulator
result
Loeys–Dietz
syndrome
(3)
give
rise
recessive
congenital
hearing
impairment.
Rareservoir
provides
lightweight,
flexible
portable
system
synthesizing
phenotypic
data
required
study
tens
thousands
FEBS Journal,
Journal Year:
2021,
Volume and Issue:
288(8), P. 2461 - 2489
Published: April 1, 2021
G
protein‐coupled
receptors
(GPCRs)
play
critical
roles
in
the
regulation
of
human
physiology
response
to
a
wide
array
different
extracellular
stimuli
and
thus
represent
one
largest
groups
therapeutic
drug
targets.
Recent
advances
structural
characterization
GPCRs
conformations
complex
with
proteins
arrestins
have
provided
important
insights
into
mechanism
function
GPCRs.
However,
order
truly
understand
molecular
basis
functional
versatility
GPCRs,
snapshots
obtained
by
X‐ray
crystallography
or
cryo‐EM
need
be
complimented
information
about
conformational
dynamics
their
signaling
complexes.
In
last
decade,
combination
biophysical
approaches
computational
studies
has
been
utilized
examine
motions
transducer
complexes
how
they
are
regulated
ligands
efficacy
bias.
These
revealed
that
highly
dynamic
allosteric
can
sample
multiple
states.
Ligands
distinct
profiles
not
only
impact
landscape
but
also
receptor‐engaged
arrestins.
The
ligand‐dependent
bias
sampling
states
underlying
principles
behind
behavior
Proceedings of the National Academy of Sciences,
Journal Year:
2022,
Volume and Issue:
119(10)
Published: March 1, 2022
SignificanceAmino
acids
are
the
building
blocks
of
life
and
important
signaling
molecules.
Despite
their
common
structure,
no
universal
mechanism
for
amino
acid
recognition
by
cellular
receptors
is
currently
known.
We
discovered
a
simple
motif,
which
binds
in
various
receptor
proteins
from
all
major
life-forms.
In
humans,
this
motif
found
subunits
calcium
channels
that
implicated
pain
neurodevelopmental
disorders.
Our
findings
suggest
γ-aminobutyric
acid-derived
drugs
bind
to
same
human
natural
ligands
bacterial
receptors,
thus
enabling
future
improvement
drugs.
Molecular Biomedicine,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: Dec. 4, 2023
G
protein-coupled
receptors
(GPCRs)
are
versatile
and
vital
proteins
involved
in
a
wide
array
of
physiological
processes
responses,
such
as
sensory
perception
(e.g.,
vision,
taste,
smell),
immune
response,
hormone
regulation,
neurotransmission.
Their
diverse
essential
roles
the
body
make
them
significant
focus
for
pharmaceutical
research
drug
development.
Currently,
approximately
35%
marketed
drugs
directly
target
GPCRs,
underscoring
their
prominence
therapeutic
targets.
Recent
advances
structural
biology
have
substantially
deepened
our
understanding
GPCR
activation
mechanisms
interactions
with
G-protein
arrestin
signaling
pathways.
This
review
offers
an
in-depth
exploration
both
traditional
recent
methods
structure
analysis.
It
presents
structure-based
insights
into
ligand
recognition
receptor
delves
deeper
canonical
noncanonical
pathways
downstream
GPCRs.
Furthermore,
it
highlights
advancements
GPCR-related
discovery
Particular
emphasis
is
placed
on
selective
drugs,
allosteric
biased
signaling,
polyphamarcology,
antibody
drugs.
Our
goal
to
provide
researchers
thorough
updated
determination,
pathway
investigation,
foundation
aims
propel
forward-thinking
approaches
that
drawing
upon
latest
selectivity,
activation,
mechanisms.
Science Advances,
Journal Year:
2023,
Volume and Issue:
9(22)
Published: June 2, 2023
Allosteric
modulators
bear
great
potential
to
fine-tune
neurotransmitter
action.
Promising
targets
are
metabotropic
glutamate
(mGlu)
receptors,
which
associated
with
numerous
brain
diseases.
Orthosteric
and
allosteric
ligands
act
in
synergy
control
the
activity
of
these
multidomain
dimeric
GPCRs.
Here,
we
analyzed
effect
such
molecules
on
concerted
conformational
changes
full-length
mGlu2
at
single-molecule
level.
We
first
established
FRET
sensors
through
genetic
code
expansion
combined
click
chemistry
monitor
live
cells.
then
used
show
that
orthosteric
agonist
binding
leads
stabilization
most
domains
their
closed
state,
while
reorientation
dimer
into
active
state
remains
partial.
modulators,
interacting
transmembrane
domain,
required
stabilize
fully
reoriented
dimer.
These
results
illustrate
how
within
proteins
activity,
modulated
by
ligands.
Pharmacology & Therapeutics,
Journal Year:
2021,
Volume and Issue:
231, P. 107977 - 107977
Published: Sept. 1, 2021
G
protein-coupled
receptors
(GPCRs)
are
the
largest
group
of
involved
in
cellular
signaling
across
plasma
membrane
and
a
major
class
drug
targets.
The
canonical
model
for
GPCR
involves
three
components
—
GPCR,
heterotrimeric
protein
proximal
effector
that
have
been
generally
thought
to
be
freely
mobile
molecules
able
interact
by
'collision
coupling'.
Here,
we
synthesize
evidence
supports
existence
GPCR–effector
macromolecular
assemblies
(GEMMAs)
comprised
specific
GPCRs,
proteins,
other
associated
transmembrane
proteins
pre-assembled
prior
receptor
activation
agonists,
which
then
leads
subsequent
rearrangement
GEMMA
components.
concept
offers
an
alternative
complementary
collision-coupling
model,
allowing
more
efficient
interactions
between
components,
as
well
integration
oligomerization
with
orphan
receptors,
truncated
GPCRs
membrane-localized
GPCR-associated
proteins.
Collision-coupling
mechanisms
not
exclusive
likely
both
operate
cell,
providing
spectrum
modalities
explains
differential
properties
multitude
their
different
environments.
explore
unique
pharmacological
characteristics
individual
GEMMAs,
could
provide
new
opportunities
therapeutically
modulate
signaling.
Human
calcium-sensing
receptor
(CaSR)
is
a
G-protein-coupled
that
maintains
Ca
2+
homeostasis
in
serum.
Here,
we
present
the
cryo-electron
microscopy
structures
of
CaSR
inactive
and
agonist+PAM
bound
states.
Complemented
with
previously
reported
CaSR,
show
addition
to
full
active
states,
there
are
multiple
intermediate
states
during
activation
CaSR.
We
used
negative
allosteric
nanobody
stabilize
fully
state
found
new
binding
site
for
ion
acts
as
composite
agonist
L-amino
acid
closure
Venus
flytraps.
Our
data
leads
compaction
dimer,
proximity
cysteine-rich
domains,
large-scale
transitions
seven-transmembrane
inter-
intrasubunit
conformational
changes
domains
accommodate
downstream
transducers.
results
reveal
structural
basis
mechanisms
clarify
mode
action
ions
leading
receptor.